codon-optimised dna sequence (Bioneer Corporation)
Structured Review

Codon Optimised Dna Sequence, supplied by Bioneer Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/codon-optimised+dna+sequence/codon+optimized+genes/pmc09977887-189-9-42
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Crocodile defensin (CpoBD13) antifungal activity via pH-dependent phospholipid targeting and membrane disruption"
Article Title: Crocodile defensin (CpoBD13) antifungal activity via pH-dependent phospholipid targeting and membrane disruption
Journal: Nature Communications
doi: 10.1038/s41467-023-36280-y
Figure Legend Snippet: a Full-length peptide sequence of CpoBD13. Connecting lines represent disulphide bonds between cysteine residues. b Sequence alignment of CpoBD13 with its close homologues A. sinensis (Chinese alligator) β-defensin 13 (AsBD13, GenBank accession code AUG31287.1) and Gallus gallus (chicken) avian β-defensin 13 (AvBD13, NCBI RefSeq NP_001001780.1). c Fungal growth inhibition assay of C. albicans treated with CpoBD13 over a 24 h period. d Membrane permeabilisation of C. albicans after a 30 min treatment with CpoBD13 as determined by the uptake of propidium iodide. e MTT and MTS cell viability assay of human primary (AHDF and HUVEC) and tumourigenic (HeLa, PC3 and U937) cells treated with a range of CpoBD13 concentrations after 48 h. f Net charge of CpoBD13 at pH 5–9 highlights a sharp decrease in positive charge at pH greater than 6.0. The theoretical net charge of the peptide was calculated using a simplified method based on the pK a of free amino acids. g Membrane permeabilisation of C. albicans treated with CpoBD13 in conditions buffered to pH 5.5, 6.5 and 7.5. Data in (c–e & g) represent mean ± SEM, n = 3. h Live microscopy of C. albicans treated with 20 µM CpoBD13 conjugated to the fluorophore BODIPY FL EDA (green) in the presence of PI (orange). Images are representative of three independent experiments. i Live microscopy of the accumulation of CpoBD13-BODIPY (20 µM, green) at the plasma membrane of C. albicans cells. Scale bars represent 10 µm. Images are representative of three independent experiments. (c–g) Source data are provided as a Source Data file.
Techniques Used: Sequencing, Growth Inhibition Assay, Membrane, Viability Assay, Microscopy, Clinical Proteomics
Figure Legend Snippet: a Immunodetection of CpoBD13-HA overlayed on a PIP Strip shows specific binding to PA. b Liposome pulldown comparing the binding of CpoBD13 to PC only and PC:PA (95:5 molar ratio) liposomes. Bound (B, black) and Unbound (U, white) fractions were subjected to SDS-PAGE analysis and colloidal Coomassie staining. The intensities of the bands were calculated as a fraction of a 1 µg loading control (LC) using ImageJ software. Data represent mean ± SEM, n = 3. * P < 0.05, two-tailed unpaired t test. c Liposome lysis of calcein-encapsulated PC only (white) and PC:PA (black) liposomes by 20 µM CpoBD13 over 30 min. Lysis was calculated as a fraction of a 100% lysis control using 0.1% Triton X-100. Data represent mean ± SEM, n = 3. *** P = 0.0009, two-way ANOVA. d Chemical crosslinking of CpoBD13 using BS(PEG) 5 in the presence of various concentrations of PA followed by SDS-PAGE analysis and colloidal Coomassie staining. Image is representative of three independent experiments. e TEM imag e s of CpoBD13 alone, PA alone or CpoBD13:PA complexes (scale bars represent 1 µm). Images are representative of two independent experiments. (a–d) Source data are provided as a Source Data file.
Techniques Used: Immunodetection, Stripping Membranes, Binding Assay, Liposomes, SDS Page, Staining, Control, Software, Two Tailed Test, Lysis
Figure Legend Snippet: a Three-dimensional structure of CpoBD13 determined by X-ray crystallography superimposed with HBD-2 (PDB ID 1FD3). Zoomed in region shows the substitution of K36 (a crucial residue for membranolytic activity) in HBD-2 for H35 in CpoBD13. b Four CpoBD13 chains are found in the asymmetric unit (white, cyan, steel blue and magenta cartoon), bound to four PA molecules shown as green sticks. c Type I and d Type II PA binding sites. Key interacting residues are shown as sticks. Hydrogen bonds or ionic interactions are marked as black dashed lines. Schematic representation of the e Type I and f Type II PA binding sites. g CpoBD13:PA complex forms a single-stranded left-handed helix. The coil shown comprises the content of four asymmetric units. The location of a single type I PA binding site is boxed in black.
Techniques Used: Residue, Activity Assay, Binding Assay
Figure Legend Snippet: Data represent ± SEM, n = 3. All statistical evaluations are comparisons to the corresponding CpoBD13 wild type sample. ns, not significant, * P < 0.05, ** P < 0.01, **** P < 0.0001 two-tailed unpaired t test. Exact P values are stated above their respective graphs. a Fungal growth inhibition of C. albicans treated with wild type or mutant CpoBD13 over 24 h. b Calculated IC 50 values of the fungal growth curves. # The IC 50 of CpoBD13 (H21A) could not be determined within the assessed concentration range (0–10 µM). c Membrane permeabilisation of C. albicans treated with wild type or mutant CpoBD13 for 30 min as determined by the uptake of PI. d Membrane permeabilisation of C. albicans in pH buffered conditions (pH 5.5 = solid line, pH 7.5 = dashed line) treated with wild type or mutant CpoBD13 for 30 min. e Liposome pulldown quantification of the bound fractions of PC only (white) and 95:5 molar ratio PC:PA (black) liposomes incubated with 1 µg of CpoBD13 or its mutants performed at pH 7.4 and f again at pH 5.5. g Liposome lysis of calcein-encapsulated PC only and PC:PA liposomes by 20 µM wild type or mutant CpoBD13 over 30 min. Lysis was calculated as a fraction of a 100% lysis control using 0.1% Triton X-100. h Biochemical crosslinking of wild type or mutant CpoBD13 using BS(PEG) 5 in the presence of PA followed by SDS-PAGE analysis and colloidal Coomassie staining. Image is representative of three independent experiments. (a–h) Source data are provided as a Source Data file.
Techniques Used: Two Tailed Test, Inhibition, Mutagenesis, Concentration Assay, Membrane, Liposomes, Incubation, Lysis, Control, SDS Page, Staining
Figure Legend Snippet: a Sequence alignment of CpoBD13 with the designed compound mutants. Residues that differ from wild type CpoBD13 are highlighted in black. b Fungal growth inhibition of C. albicans treated with a range of CpoBD13 and CpoBD13 compound mutant concentrations over 24 h. Data represent mean ± SEM, n = 3. c Calculated IC 50 values of the fungal growth curves. Data represent mean ± SEM, n = 3. All statistical evaluations are comparisons to the corresponding CpoBD13 wild type sample. ** P < 0.01, *** P < 0.001, **** P < 0.0001, two-tailed unpaired t test. Exact P values are stated above their respective graphs. d Membrane permeabilisation of C. albicans in pH-buffered conditions (pH 5.5 = solid line, pH 7.5 = dashed line) treated with CpoBD13 (H21A/H35A) (purple) and CpoBD13 (H21R/H35R) (orange) for 30 min. Data represent mean ± SEM, n = 3. ns, not significant, two-way ANOVA. ( b–d ) Source data are provided as a Source Data file.
Techniques Used: Sequencing, Inhibition, Mutagenesis, Two Tailed Test, Membrane
Related Articles
other:Article Title: A structure-based mechanism of adenosylcobinamide kinase/adenosylcobinamide phosphate guanylyltransferase (MpaCobU) from Methylocapsa palsarum. Article Snippet: The gene encoding MpaCobU (NCBI Accession number: WP_091681217.1) was synthesized using Article Title: Binding inhibitor between TCTP dimer type IgE-dependent histamine releasing factor and receptor thereof, and use thereof Article Snippet: The Article Title: Structural insights into the distinct substrate preferences of two bacterial epoxide hydrolases. Article Snippet: Epoxide hydrolases (EHs), which catalyze the transformation of epoxides to diols, are present in many eukaryotic and prokaryotic organisms.. They have recently drawn considerable attention from organic chemists owing to their application in the semisynthesis of enantiospecific diol compounds.. Here, we report the crystal structures of BoEH from Bosea sp. PAMC 26642 and CaEH from Caballeronia sordidicola PAMC 26510 at 1.95 and 2.43 Å resolution, respectively. Article Title: The Conformational Change of the L3 Loop Affects the Structural Changes in the Substrate Binding Pocket Entrance of β-Glucosidase Article Snippet: Briefly, codon-optimized TsaBgl (UniProt: I3VXG7) was synthesized and cloned into the pBT7 vector (Bioneer, Daejeon, Republic of Korea). Article Title: Algal biomass-based zero-waste biorefinery for producing optically pure (R)-γ-valerolactone and carbonaceous electrodes applicable for energy storage devices Article Snippet: The codon-optimized HBDH genes for expression in Article Title: Analytical sensitivity of COVID-19 rapid antigen tests: A case for a robust reference standard Article Snippet: The Sequencing:Article Title: Crocodile defensin (CpoBD13) antifungal activity via pH-dependent phospholipid targeting and membrane disruption Article Snippet: .. The Software:Article Title: Crocodile defensin (CpoBD13) antifungal activity via pH-dependent phospholipid targeting and membrane disruption Article Snippet: .. The Expressing:Article Title: Crocodile defensin (CpoBD13) antifungal activity via pH-dependent phospholipid targeting and membrane disruption Article Snippet: .. The Plasmid Preparation:Article Title: Crocodile defensin (CpoBD13) antifungal activity via pH-dependent phospholipid targeting and membrane disruption Article Snippet: .. The Recombinant:Article Title: Crocodile defensin (CpoBD13) antifungal activity via pH-dependent phospholipid targeting and membrane disruption Article Snippet: .. The Purification:Article Title: Crocodile defensin (CpoBD13) antifungal activity via pH-dependent phospholipid targeting and membrane disruption Article Snippet: .. The Chromatography:Article Title: Crocodile defensin (CpoBD13) antifungal activity via pH-dependent phospholipid targeting and membrane disruption Article Snippet: .. The Derivative Assay:Article Title: Enzymatic production of 2'-fucosyllactose from l-fucose derived from acid-hydrolyzed Ishige foliacea using a bifunctional fucokinase/l-fucose 1-l-P guanyltransferase system. Article Snippet: • 2′-FL was produced from L-fucose of Ishige foliacea using a bifunctional Synthesized:Article Title: Enzymatic production of 2'-fucosyllactose from l-fucose derived from acid-hydrolyzed Ishige foliacea using a bifunctional fucokinase/l-fucose 1-l-P guanyltransferase system. Article Snippet: • 2′-FL was produced from L-fucose of Ishige foliacea using a bifunctional |